CLINICAL_TRIALS
trial_result
· 2025-06-11
Clinical Trial Update: Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome [Phase 2]
Summary
A Phase 2 trial of Staccato Granisetron (AZ 010) for cyclic vomiting syndrome has completed, and results have been posted (June 2025).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Cyclic Vomiting Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-06-11